MX2007011024A - Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin. - Google Patents
Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin.Info
- Publication number
- MX2007011024A MX2007011024A MX2007011024A MX2007011024A MX2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A MX 2007011024 A MX2007011024 A MX 2007011024A
- Authority
- MX
- Mexico
- Prior art keywords
- biomarkers
- ovarian cancer
- cancer
- hepcidin
- endometrial
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
La presente invención proporciona biomarcadores a base de proteína y combinaciones de biomarcadores que son útiles en calificar estados de cáncer de ovario, así como estados de cáncer endometrial en un paciente. En particular, se ha descubierto que hepcidin es un biomarcador tanto para cáncer de ovario como para cáncer endometrial y que un panel de biomarcadores, incluyendo hepcidin, transtiretin y opcionalmente otros marcadores son útiles para clasificar la muestra de un sujeto como cáncer de ovario o no cáncer de ovario. Los biomarcadores pueden ser detectados mediante espectrometría de masa SELDI.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66209005P | 2005-03-11 | 2005-03-11 | |
PCT/US2006/008578 WO2006099126A2 (en) | 2005-03-11 | 2006-03-10 | Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007011024A true MX2007011024A (es) | 2009-11-23 |
Family
ID=36992262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007011024A MX2007011024A (es) | 2005-03-11 | 2006-03-10 | Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin. |
Country Status (11)
Country | Link |
---|---|
US (2) | US7510842B2 (es) |
EP (1) | EP1869462B1 (es) |
JP (1) | JP5069214B2 (es) |
KR (1) | KR101310000B1 (es) |
CN (1) | CN101189516A (es) |
AU (1) | AU2006223374B2 (es) |
CA (1) | CA2602088C (es) |
IL (1) | IL185496A (es) |
MX (1) | MX2007011024A (es) |
NZ (1) | NZ560976A (es) |
WO (1) | WO2006099126A2 (es) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
WO2012047930A2 (en) | 2010-10-04 | 2012-04-12 | The Regents Of The University Of California | Compositions and methods for treatment of gynecologic cancers |
US9488655B2 (en) * | 2004-07-14 | 2016-11-08 | The Regents Of The University Of California | Biomarkers for detection of early- and late-stage endometrial cancer |
EP1789805B1 (en) * | 2004-07-14 | 2010-09-15 | The Regents of The University of California | Biomarker for early detection of ovarian cancer |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
JP4801930B2 (ja) * | 2005-05-02 | 2011-10-26 | 株式会社Mcbi | 新規肝がんバイオマーカーおよび該バイオマーカーを用いた肝がんの検出方法 |
CN101243319B (zh) * | 2005-06-22 | 2016-01-06 | 约翰·霍普金斯大学 | 卵巢癌的生物标记:ctap3-相关蛋白质 |
JP2008547028A (ja) * | 2005-06-24 | 2008-12-25 | サイファージェン バイオシステムズ, インコーポレイテッド | 卵巣癌用のバイオマーカー |
US7672916B2 (en) * | 2005-08-16 | 2010-03-02 | The Trustees Of Columbia University In The City Of New York | Methods, systems, and media for music classification |
WO2007022248A2 (en) * | 2005-08-16 | 2007-02-22 | Sloan Kettering Institute For Cancer Research | Methods of detection of cancer using peptide profiles |
WO2007081386A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
EP2481815B1 (en) | 2006-05-11 | 2016-01-27 | Raindance Technologies, Inc. | Microfluidic devices |
ES2446266T3 (es) * | 2006-07-21 | 2014-03-06 | Amgen Inc. | Método de detección y/o de medición de hepcidina en una muestra |
WO2008021123A1 (en) | 2006-08-07 | 2008-02-21 | President And Fellows Of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
WO2008060376A2 (en) * | 2006-10-04 | 2008-05-22 | The Johns Hopkins University | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer |
WO2008048508A2 (en) * | 2006-10-13 | 2008-04-24 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
US20110053268A1 (en) * | 2006-10-17 | 2011-03-03 | Naohisa Tomosugi | Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator |
WO2008049175A1 (en) * | 2006-10-24 | 2008-05-02 | Katholieke Universiteit Leuven | High discriminating power biomarker diagnosing |
US8329399B2 (en) * | 2006-10-27 | 2012-12-11 | Siu K W Michael | Endometrial biomarkers |
TW201307390A (zh) * | 2007-02-02 | 2013-02-16 | Amgen Inc | 海帕西啶(hepcidin)、海帕西啶拮抗劑及使用方法 |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
JP2010522882A (ja) * | 2007-03-27 | 2010-07-08 | ヴァーミリオン インコーポレイテッド | 卵巣癌のバイオマーカー |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
JPWO2008146903A1 (ja) * | 2007-05-31 | 2010-08-19 | 直久 友杉 | 活性型ヘプシジンを指標とした、急性虚血性疾患の診断方法 |
JP2010532484A (ja) | 2007-06-29 | 2010-10-07 | コレロジック システムズ,インコーポレイテッド | 卵巣癌のための予測マーカー |
KR20100058496A (ko) * | 2007-07-20 | 2010-06-03 | 더 유니버시티 오브 유타 리서치 파운데이션 | 조산의 위험을 평가하기 위한 바이오마커의 확인 및 정량화 |
US8039227B2 (en) * | 2007-09-20 | 2011-10-18 | University Of Louisville Research Foundation, Inc. | Peptide biomarkers predictive of renal function decline and kidney disease |
EP2220506B1 (en) * | 2007-10-29 | 2013-10-02 | Vermillion, Inc. | Biomarkers for the detection of early stage ovarian cancer |
CL2008003190A1 (es) | 2007-11-02 | 2009-09-04 | Lilly Co Eli | Anticuerpo que se enlaza selectivamente a hepcidina-25 humana madura; polinucleotido codificante, vector y celula huesped que lo comprende; uso medico para tratar la anemia, incrementar nivel de hierro, conteo de rediculocito, celulas rojas, hemoglobina, o hematocritos; proceso de produccion; composicion farmaceutica. |
WO2009065230A1 (en) * | 2007-11-23 | 2009-05-28 | British Columbia Cancer Agency Branch | Methods for detecting lung cancer and monitoring treatment response |
EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
PT2325648E (pt) * | 2008-08-05 | 2014-06-24 | Toray Industries | Método para detetar cancro |
KR101638490B1 (ko) | 2008-08-05 | 2016-07-11 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
CA2733497C (en) * | 2008-08-06 | 2015-06-02 | Eli Lilly And Company | Anti-hepcidin-25 selective antibodies and uses thereof |
US20100068737A1 (en) * | 2008-09-16 | 2010-03-18 | University Of Tennessee Research Foundation | Enzyme-linked Immunosorbent Assay (ELISA) for Canine Hepcidin |
WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
EP2273272A1 (en) | 2009-07-06 | 2011-01-12 | Stichting Katholieke Universiteit | Method for predicting the outcome of chemotherapy in ovarian cancer |
EP2486409A1 (en) | 2009-10-09 | 2012-08-15 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
HUE040012T2 (hu) | 2010-02-04 | 2019-02-28 | Toray Industries | Gyógyászati ágens rák kezelésére és/vagy megelõzésére |
PT2532743E (pt) | 2010-02-04 | 2015-08-04 | Toray Industries | Composição farmacêutica para o tratamento e/ou a prevenção de cancro |
PL2532365T3 (pl) | 2010-02-04 | 2016-12-30 | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
RU2567657C2 (ru) | 2010-02-04 | 2015-11-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
HUE030742T2 (en) | 2010-02-04 | 2017-06-28 | Toray Industries | A pharmaceutical composition for the treatment and / or prevention of cancer |
US8911740B2 (en) | 2010-02-04 | 2014-12-16 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
US9321818B2 (en) * | 2010-02-09 | 2016-04-26 | Academia Sinica | Dermcidin-derived peptides for lung cancer diagnostics |
JP5934657B2 (ja) | 2010-02-12 | 2016-06-15 | レインダンス テクノロジーズ, インコーポレイテッド | デジタル検体分析 |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
WO2011149942A2 (en) * | 2010-05-24 | 2011-12-01 | Children's Medical Center Corporation | Compositions and methods for plasma peptide analysis |
US20120046185A1 (en) * | 2010-08-06 | 2012-02-23 | Vermillion, Inc. | Panel of biomarkers for ovarian cancer |
CN102375063A (zh) * | 2010-08-23 | 2012-03-14 | 湖州赛尔迪生物医药科技有限公司 | 一种常见蛋白质的免疫质谱试剂盒及制备方法 |
EP2622103B2 (en) | 2010-09-30 | 2022-11-16 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
AU2011316844A1 (en) * | 2010-10-22 | 2013-06-06 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
EP3412778A1 (en) | 2011-02-11 | 2018-12-12 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
EP3736281A1 (en) | 2011-02-18 | 2020-11-11 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
DE202012013668U1 (de) | 2011-06-02 | 2019-04-18 | Raindance Technologies, Inc. | Enzymquantifizierung |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
BR112014002621B1 (pt) | 2011-08-04 | 2022-09-20 | Toray Industries, Inc | Anticorpo, ou seu fragmento, composição farmacêutica, uso de um anticorpo e uso de uma composição farmacêutica |
AU2012290949B2 (en) | 2011-08-04 | 2017-03-02 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
KR101980554B1 (ko) | 2011-08-04 | 2019-05-21 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
EP2740798B1 (en) | 2011-08-04 | 2016-12-07 | Toray Industries, Inc. | Cancer treatment and/or prevention drug composition |
MX349907B (es) | 2011-08-04 | 2017-08-18 | Toray Industries | Metodo para detectar cancer pancreatico. |
RU2610428C2 (ru) | 2011-08-04 | 2017-02-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
CN103717740B (zh) | 2011-08-04 | 2015-10-21 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
KR20140063747A (ko) | 2011-08-29 | 2014-05-27 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 전염증성 상태를 치료 및 예방하기 위한 hdl-관련 분자의 용도 |
US20130210659A1 (en) | 2012-02-10 | 2013-08-15 | Andrew Watson | Molecular diagnostic screening assay |
PL2824114T3 (pl) | 2012-02-21 | 2019-11-29 | Toray Industries | Kompozycja farmaceutyczna do leczenia nowotworu |
HUE044611T2 (hu) | 2012-02-21 | 2019-11-28 | Toray Industries | Gyógyászati készítmény rák kezelésére |
ES2749672T3 (es) | 2012-02-21 | 2020-03-23 | Toray Industries | Composición farmacéutica para tratar y/o prevenir el cáncer |
PL2818483T3 (pl) | 2012-02-21 | 2018-01-31 | Toray Industries | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi |
JP6107654B2 (ja) | 2012-03-30 | 2017-04-05 | 東レ株式会社 | 肝臓癌の治療及び/又は予防用医薬組成物 |
PL2832366T3 (pl) | 2012-03-30 | 2018-04-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania rakowi pęcherzyka żółciowego |
WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
PT2876446T (pt) | 2012-07-19 | 2019-03-25 | Toray Industries | Método para deteção de cancro |
KR102056137B1 (ko) | 2012-07-19 | 2019-12-16 | 도레이 카부시키가이샤 | 암의 검출 방법 |
NZ631098A (en) * | 2013-03-15 | 2016-09-30 | Intrinsic Lifesciences Llc | Anti-hepcidin antibodies and uses thereof |
EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
JP6447130B2 (ja) | 2013-08-09 | 2019-01-09 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
TWI598577B (zh) * | 2014-03-28 | 2017-09-11 | Metallogenics Co Ltd | Method for obtaining data for determining possibility of carcinogenesis of endometriotic ovarian cysts, and diagnostic apparatus thereof |
NZ730186A (en) | 2014-09-22 | 2020-04-24 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
GB2530521B (en) * | 2014-09-24 | 2020-06-10 | Map Ip Holding Ltd | Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin |
JP2017535750A (ja) * | 2014-09-24 | 2017-11-30 | マップ アイピー ホールディング リミテッド | 妊娠の予後を提供する方法 |
IL256399B (en) | 2015-06-19 | 2022-09-01 | Sera Prognostics Inc | Pairs of biomarkers for predicting premature birth |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
CN106872593B (zh) * | 2017-02-04 | 2021-05-04 | 江西省妇幼保健院 | 溶血磷脂酸作为标志物在检测子宫内膜异位症中的应用 |
EP3668996A4 (en) | 2017-08-18 | 2021-04-21 | Sera Prognostics, Inc. | CLOCK PREGNANCY PROTEIN FOR PREDICTING THE DATE AND TIME TO BIRTH |
US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
KR20240019862A (ko) | 2017-09-01 | 2024-02-14 | 벤 바이오사이언시스 코포레이션 | 진단 및 치료 모니터링용 바이오마커로서의 당펩티드의 식별 및 용도 |
CN108152430A (zh) * | 2017-12-21 | 2018-06-12 | 上海中科新生命生物科技有限公司 | 基于prm检测的卵巢癌标志物检测试剂盒及检测方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6283761B1 (en) | 1992-09-08 | 2001-09-04 | Raymond Anthony Joao | Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information |
US6177545B1 (en) * | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
AU2003235749A1 (en) * | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
EP1540010B8 (en) | 2002-08-06 | 2010-07-14 | The Johns Hopkins University | Use of biomarkers for detecting ovarian cancer |
US7749713B2 (en) * | 2002-11-19 | 2010-07-06 | Hasan Kulaksiz | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
WO2004105573A2 (en) * | 2003-05-21 | 2004-12-09 | The Wistar Institute Of Anatomy And Biology | Method of diagnosis of cancer based on gene expression profiles in cells |
KR20060031809A (ko) * | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
US7670792B2 (en) * | 2004-07-14 | 2010-03-02 | The Regents Of The University Of California | Biomarkers for early detection of ovarian cancer |
JP2008547028A (ja) * | 2005-06-24 | 2008-12-25 | サイファージェン バイオシステムズ, インコーポレイテッド | 卵巣癌用のバイオマーカー |
-
2006
- 2006-03-10 KR KR1020077023307A patent/KR101310000B1/ko active IP Right Grant
- 2006-03-10 AU AU2006223374A patent/AU2006223374B2/en active Active
- 2006-03-10 MX MX2007011024A patent/MX2007011024A/es active IP Right Grant
- 2006-03-10 WO PCT/US2006/008578 patent/WO2006099126A2/en active Application Filing
- 2006-03-10 EP EP06737729.1A patent/EP1869462B1/en active Active
- 2006-03-10 CA CA2602088A patent/CA2602088C/en active Active
- 2006-03-10 NZ NZ560976A patent/NZ560976A/en unknown
- 2006-03-10 US US11/373,833 patent/US7510842B2/en active Active
- 2006-03-10 JP JP2008500963A patent/JP5069214B2/ja active Active
- 2006-03-10 CN CNA2006800078086A patent/CN101189516A/zh active Pending
-
2007
- 2007-08-23 IL IL185496A patent/IL185496A/en active IP Right Grant
-
2009
- 2009-03-09 US US12/381,218 patent/US20100068724A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008533471A (ja) | 2008-08-21 |
IL185496A (en) | 2012-07-31 |
KR20080044801A (ko) | 2008-05-21 |
EP1869462A4 (en) | 2009-01-14 |
CN101189516A (zh) | 2008-05-28 |
CA2602088A1 (en) | 2006-09-21 |
US20070054329A1 (en) | 2007-03-08 |
AU2006223374B2 (en) | 2011-07-21 |
EP1869462B1 (en) | 2013-05-08 |
EP1869462A2 (en) | 2007-12-26 |
US20100068724A1 (en) | 2010-03-18 |
NZ560976A (en) | 2011-06-30 |
AU2006223374A1 (en) | 2006-09-21 |
WO2006099126A2 (en) | 2006-09-21 |
US7510842B2 (en) | 2009-03-31 |
WO2006099126A3 (en) | 2006-12-07 |
JP5069214B2 (ja) | 2012-11-07 |
KR101310000B1 (ko) | 2013-09-25 |
IL185496A0 (en) | 2008-01-06 |
CA2602088C (en) | 2021-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007011024A (es) | Biomarcadores para cancer de ovario y cancer de endometrio: hepcidin. | |
IL251791A0 (en) | Ovarian cancer biomarkers: ctap3-related proteins | |
WO2007002535A3 (en) | Biomarkers for ovarian cancer | |
WO2007035766A3 (en) | Biomarker for prostate cancer | |
WO2006034032A3 (en) | Biomarkers for breast cancer | |
WO2007002527A3 (en) | BIOMARKERS FOR OVARIAN CANCER: β-2 MICROGLOBULIN | |
WO2006089125A3 (en) | Methods of detecting ovarian cancer | |
WO2006128082A3 (en) | Biomarkers for breast cancer | |
WO2006074430A3 (en) | Biomarkers for melanoma | |
CA2697508A1 (en) | Method for detecting gynecologic cancer | |
IL252832A0 (en) | Use of biomarkers to detect ovarian cancer | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
WO2007118222A3 (en) | Compositions for the use in identification of fungi | |
WO2009037572A3 (en) | Biomarker combinations for colorectal cancer | |
EP1844322A4 (en) | METHOD FOR IDENTIFICATION OF BIOMARKERS BY MEANS OF MASS SPECTROMETRY TECHNIQUES | |
EA201070855A1 (ru) | Композиции и процессы для улучшенного масс-спектрометрического анализа | |
TW200704927A (en) | Mass spectrometric analysis of ligand conjugated magnetic nanoparticles | |
WO2007087534A3 (en) | Methods, mixtures, kits and compositions pertaining to analyte determination | |
EP1891433A4 (en) | METHOD FOR CLASSIFYING CHEMICALLY CROSS-LINKED CELLULAR SAMPLES BY MASS SPECTRUM | |
WO2009073505A3 (en) | Methods for processing tandem mass spectral data for protein sequence analysis | |
SG127861A1 (en) | in situ biomarker identification | |
EP1869468A4 (en) | COLLOIDAL METAL CONJUGATES | |
WO2005044794A3 (en) | Immunohistochemical methods | |
WO2009058331A3 (en) | Biomarkers for the detection of early stage ovarian cancer | |
WO2013044187A3 (en) | Detecting ovarian cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |